Skip to main content
×
Home

Estimating hepatitis C infection acquired in England, 1986–2000

  • M. A. BALOGUN (a1), A. J. VYSE (a1), L. M. HESKETH (a2), G. KAFATOS (a3), J. V. PARRY (a4) (a5) and M. E. RAMSAY (a1)...
Summary
SUMMARY

Hepatitis C is a global health problem and in the UK seroprevalence studies have mainly concentrated on specific high-risk groups. The aim of this study was to determine changes in the prevalence of antibody to hepatitis C virus in England using residual specimens collected between 1986 and 2000 reflecting the general population. A cross-sectional study design using a convenience collection of serum specimens from adult patients submitted to laboratories in the years 1986, 1991, 1996 and 2000 from a total of 19 laboratories around England were investigated. The main outcome was to determine anti-HCV prevalence and the average incidence occurring between 1986 and 2000 and factors associated with infection. Multivariable analysis of results from all years showed there was a significant difference in prevalence between males and females (P<0·001), birth cohort (P<0·001) and by health region (P<0·001). An average of 0·72% (95% CI 0–1·65%) of those susceptible to HCV born between 1950 and 1970 were estimated to have acquired the infection between 1986 and 2000. Analysis of this convenience serum collection suggests that HCV prevalence is low in the general population, and is associated with period of birth, gender and health region. There was evidence to support a low incidence of HCV infection in those born between 1950 and 1970 over the period 1986–2000 which, at the population level, equated to a substantial burden of infection (~106 000 persons). Continued surveillance and prevention targeted at injecting drug users are essential for the control of hepatitis C in the UK.

Copyright
Corresponding author
*Author for correspondence: Dr M. A. Balogun, Health Protection Agency, Centre for Infections, Immunisation Department, 61 Colindale Avenue, London NW9 5EQ, UK. (Email: koye.balogun@hpa.org.uk)
References
Hide All
1. Anon. Hepatitis C – global prevalence (update). Weekly Epidemiology Record 1999; 74: 425427.
2. Majid A, et al. Molecular epidemiology of hepatitis C virus infection amongst intravenous drug users in rural communities. Journal of Medical Virology 1995; 46: 4851.
3. Lamden KH, et al. Hepatitis B and hepatitis C virus infections: Risk factors among drug users in North West England. Journal of Infection 1998; 17: 260269.
4. Hope V, et al. Prevalence of hepatitis C among injection drug users in England and Wales. Is harm reduction working? American Journal of Public Health 2001; 91: 3842.
5. Hutchinson SJ, et al. Prevalence of hepatitis C among injectors in Scotland 1989–2000; declining trends among young injectors halt in the late 1990s. Epidemiology and Infection 2002; 128: 473477.
6. Soldan K, Barbara JAJ, Heptonstall J. Incidence of seroconversion to positivity for hepatitis C antibody in repeat blood donors in England, 1993–5. British Medical Journal 1998; 316: 14131417.
7. Balogun MA, et al. The prevalence and genetic diversity of hepatitis C infection in antenatal clinic attenders in two regions of England. Epidemiology and Infection 2000; 125: 705712.
8. Ward G, et al. Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing. Gut 2000; 47: 277280.
9. Goldberg D, et al. Hepatitis C virus among high and low risk pregnant women in Dundee: unlinked anonymous testing. British Journal of Obstetrics and Gynaecology 2001; 108: 365370.
10. Wreghitt TG, et al. Transmission of hepatitis C virus by organ transplantation in the United Kingdom. Journal of Hepatology 1994; 20: 768772.
11. Zuckerman J, et al. Prevalence of hepatitis C antibodies in clinical health care workers. Lancet 1994; 343: 16181620.
12. HPA. Hepatitis C in England: The Health Protection Agency Annual Report 2007. London: Health Protection Agency Centre for Infections, December 2007.
13. Balogun MA, et al. The prevalence of hepatitis C in England and Wales. Journal of Infection 2002; 45: 119226.
14. Osborne K, et al. Ten years of serological surveillance in England and Wales: methods, results, implications and action. International Journal of Epidemiology 2000; 29: 362368.
15. Vyse AJ, et al. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiology and Infection 2006; 134: 13031312.
16. Vyse AJ, et al. Seroprevalence of antibody to varicella zoster virus in England and Wales in children and young adults. Epidemiology and Infection 2004; 132: 11291134.
17. Nardone A, et al. Seroepidemiology of Bordetella pertussis in England and Wales. Vaccine 2004; 22: 13141319.
18. Vyse AJ, et al. The burden of Helicobacter pylori in England and Wales. Epidemiology and Infection 2002; 128: 411417.
19. Maple PAC, et al. Immunity to diphtheria and tetanus in England and Wales. Vaccine 2001; 19: 167173.
20. Morris MC, et al. The changing epidemiological pattern of hepatitis A in England and Wales. Epidemiology and Infection 2002; 128: 457463.
21. Vyse AJ, Hesketh LM, Pebody R. The burden of infection with cytomegalovirus in England and Wales: how many women are infected in pregnancy? Epidemiology and Infection. Published online: 15 September 2008. doi:10.1017/S0950268808001258.
22. Kelly H, et al. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine 2002; 20: 31303136.
23. Gungabissoon U, Balogun MA, Ramsay ME. Hepatitis C virus: laboratory surveillance in England and Wales, 1992–2004. Epidemiology and Infection 2007; 135: 541548.
24. Balogun MA, et al. A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection. Sexually Transmitted Infections 2003; 79: 301306.
25. Brant LJ, et al. Sentinel laboratory surveillance of hepatitis C antibody testing in England: understanding the epidemiology of HCV infection. Epidemiology and Infection 2007; 135: 417426.
26. HPA. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, CRDHB and the UASSG. Shooting up: Infections among injecting drug users in the United Kingdom 2005. London: Health Protection Agency, October 2006.
27. Sutton AJ, et al. Modelling the characteristics of the male injecting drug user population in England and Wales. International Journal of Drug Policy 2005; 16: 176182.
28. Sweeting M, et al. The burden of hepatitis C in England. Journal of Viral Hepatitis 2007; 14: 570576.
29. Hughes G, Simms I, Leong G. Data from UK genitourinary medicine clinics, 2006: a mixed picture. Sexually Transmitted Infections 2007; 83: 433435.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 1
Total number of PDF views: 7 *
Loading metrics...

Abstract views

Total abstract views: 42 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 20th November 2017. This data will be updated every 24 hours.